F H Xu
Overview
Explore the profile of F H Xu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
168
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shao D, Zhao Z, Zhang Y, Zhou X, Zhao L, Dong M, et al.
Braz J Med Biol Res
. 2021 Jan;
54(3):e10010.
PMID: 33470386
We aimed to conduct a meta-analysis to evaluate the efficacy of repetitive transcranial magnetic stimulation (rTMS) in patients with post-stroke depression (PSD). Six relevant electronic databases (PubMed, CENTRAL, Embase, Web...
2.
Jiang D, Xu F, Liu M, Chen X, Li M, Liu Y, et al.
J Musculoskelet Neuronal Interact
. 2007 Jul;
7(2):149-54.
PMID: 17627084
Osteoporosis is a major health problem, mainly characterized by low bone mineral density (BMD). Osteocalcin (also known as BGP, for bone Gla protein) is a significant biomarker of bone turnover...
3.
Deng H, Livshits G, Yakovenko K, Xu F, Conway T, Davies K, et al.
Ann Hum Genet
. 2002 May;
66(Pt 1):61-74.
PMID: 12015001
Bone mineral content (BMC) and/or bone mineral density (BMD, i.e. BMC scaled by bone size) are major determinants for osteoporosis, which is a serious health problem. The major determinant of...
4.
Deng H, Lai D, Conway T, Li J, Xu F, Davies K, et al.
J Clin Densitom
. 2001 Dec;
4(4):353-61.
PMID: 11748340
In this study, we simultaneously characterized genetic and lifestyle factors (exercise, smoking, and alcohol consumption) in determining variation in body mass index (BMI), fat mass, percentage of fat mass (PFM),...
5.
Gao F, Xu F, Zhou X, Han X, Liu Y
Acta Pharmacol Sin
. 2001 Dec;
22(6):524-9.
PMID: 11747759
Aim: To investigate the anti-implantation mechanism of mifepriston. Methods: In situ hybridization and immunohistochemistry were applied to determine mRNA and protein. Results: After mifepriston injection, the number of implantation sites...
6.
Deng H, Xu F, Conway T, Deng X, Li J, Davies K, et al.
J Clin Endocrinol Metab
. 2001 Aug;
86(8):3735-41.
PMID: 11502804
Our purpose is to test linkage of human chromosome 11q12-13 to BMD variation. Chromosome 11q12-13 has been linked to three BMD-related phenotypes that are inherited as Mendelian traits in human...
7.
Xu F, Uebaba K, Cyong J
Acupunct Electrother Res
. 1999 Dec;
24(2):89-104.
PMID: 10579241
Contingent negative variation (CNV) is a brain function test of the central nervous system in reference to attention, will preparation and motivation. We compared the neuropharmacological effects of 6 main...
8.
Xu F, Uebaba K
Acupunct Electrother Res
. 1999 Sep;
24(1):11-28.
PMID: 10472819
The pharmacological action of 6 main Kampo formulations (1.Mao -to: [Japanese pictograph see text] MA HUANG TANG; 2. Shimbu -to: [Japanese pictograph see text]: ZHEN WU TANG; 3. Ninjin -to:...
9.
Xu F, Sharma S, Gardner A, Tu Y, Raitano A, Sawyers C, et al.
Blood
. 1998 Jun;
92(1):241-51.
PMID: 9639523
The mechanism by which interleukin-6 (IL-6) protects multiple myeloma (MM) plasma cells from apoptosis induced by anti-fas antibodies and dexamethasone was studied. Anti-apoptotic concentrations of IL-6 had no effect on...
10.
Gardner A, Xu F, Fady C, Sarafian T, Tu Y, Lichtenstein A
Cell Death Differ
. 1997 Aug;
4(6):487-96.
PMID: 16465270
We contrasted possible protection against apoptosis afforded by either BCL-2 expression or anti-oxidant inhibitors in the same tumor target challenged by two distinct triggers of apoptosis. Exposure of L929 fibroblasts...